Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for Medicare, which has long been barred from covering weight loss […]
Changes in gut microbiota after bariatric surgery are strongly linked to altered metabolic health and sustained improvement in type 2 diabetes, according to a study led by researchers at the University of Gothenburg.This article was […]
Weight gain during menopause is common, with abdominal obesity being especially common and unhealthy. A new study based on data from the Study of Women’s Health Across the Nation (SWAN) has found that in addition […]
As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.This article was originally published on […]
Nearly 40% of the population in the United States develop obesity, which is linked to the development of several diseases, including type 2 diabetes and metabolic liver disease. The rise in obesity is, in part, […]
By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans. This growth is likely to increase the burden of age-related diseases, particularly […]
Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions have grown exponentially—from less than 4,600 prescriptions in 2018 to more […]
The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new […]
Metabolic and bariatric surgery, also known as weight-loss surgery, dramatically improves outcomes for patients with obesity and chronic kidney disease (CKD), significantly reducing the risk of kidney failure, major cardiovascular events and death, according to […]
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented at the […]
© 2025 SimplyWell.ca